Award notice Supplies

Lieky ATC skupiny B02BD04

Notice published in Slovak. The AI analysis summarises it for you in your language.

Public buyer: Všeobecná zdravotná poisťovňa, a.s.
Bratislava - mestská časť Petržalka
Place of performance: Bratislava - mestská časť Karlova Ves
Estimated value: €9,094,943 excl. VAT
Amount awarded: €9,094,943 excl. VAT
Planned end of contract: 23 September 2029
likely re-tender around March 2029
Bids received: 1
Form: Framework agreement
Multi-year contract: the buyer places orders as needs arise.
Procedure: Open procedure
Any company may submit a bid.
Publication: 29 September 2026
Notice language: Slovak

AI analysis: go for it or not?

Summary in English, criteria, documents to provide and a GO / NO GO verdict in one minute.

Unlimited analyses during the 14-day Pro trial, no card needed.

Lieky ATC skupiny B02BD04, Koagulačný faktor IX, parent rFIXFc (eftrenonakog alfa)

European codes that classify what the contract is about. They are how we find the tenders for your trade.

33621000

Contract	Winner	Amount
Lieky ATC skupiny B02BD04 Koagulačný faktor IX Všeobecná zdravotná poisťovňa, a.s. · 16 October 2026	INTEC PHARMA s.r.o.	€1,026,846
Lieky ATC skupiny B02BD02 Koagulačný faktor VIII, parent rekomb (simoktokog alfa) Všeobecná zdravotná poisťovňa, a.s. · 16 October 2026	INTEC PHARMA s.r.o.	€1,512,362
Lieky ATC skupiny B02BD02 Koagulačný faktor VIII, parent (rurioktokog alfa pegol) Všeobecná zdravotná poisťovňa, a.s. · 30 September 2026	BAX PHARMA, s.r.o.	€1,399,066
Lieky ATC skupiny B02BD05 Všeobecná zdravotná poisťovňa, a.s. · 15 September 2026	BAX PHARMA, s.r.o.	€825,250
Lieky ATC skupiny B02BD02 Všeobecná zdravotná poisťovňa, a.s. · 15 September 2026	ViaPharma SK s. r. o.	€4,103,168

Source : TED – Office des publications de l'Union européenne © Union européenne, données retraitées. Reference 669640-2026.